Price Move History
- Daily moves over 5%
- 64 127 sessions, September 23, 2025 to September 8, 2026
- Largest daily move
- +561.2% close of March 30, 2026
Company Description
SMNRW has declined 65.3% so far this year. The last closing price was $0.0260.
For FY2025, Semnur Pharmaceuticals and diluted earnings per share of -$0.78.
This page collects what Stock Titan holds for SMNRW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Semnur Pharmaceuticals (SMNRW) closed at $0.0260 on September 8, 2026. So far this year, the price has lost 65.3%.
SMNRW Metrics & Rankings
Price returns through September 8, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Semnur Pharmaceuticals has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form 4, 1 Form 10-Q, 1 Form SCHEDULE 13D/A. The most recent filing was submitted on August 10, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SMNRW SEC filings →
Financial Highlights
Diluted earnings per share stood at -$0.78. The company generated -$5.9M in operating cash flow. With a current ratio of 0.06, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Semnur Pharmaceuticals (SMNRW) currently stands at 3.0 thousand shares.
Days to Cover History
Days to cover for Semnur Pharmaceuticals (SMNRW) currently stands at 4.8 days, up 186.2% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 378% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 7.3 days.